Listonstreetpulse.com announces that shares of Arrayit Corporation (OTC: ARYC) common stock have hit a three-year high at $0.50. The stock has gained 455% in the past 90 calendar days. The sharp rise in ARYC stock price is consistent with the bullish “golden cross” move made by the stock a month ago.
A “golden cross” is established when a stock’s 50-day moving average crosses above the 200-day moving average. ARYC shares also show a “buy” signal in 12 of 13 short-term, medium-term, long-term and composite indicators. The technical indicators can be checked on the following link: http://www.barchart.com/opinions/stocks/ARYC. As per the P&F pattern, the initial bullish price objective for ARYC stock is $1.31: http://stockcharts.com/freecharts/gallery.html?ARYC.
In the third quarter of 2013, more than 6,800,000 common shares of ARYC have been traded, which is the highest quarterly trading volume in the company’s history. The technical indicators, when taken together, suggest that ARYC shares may trade higher in the future.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
###
